C. Perno

Pathogen Safety of Long-Term Treatments for Bleeding Disorders: (Un)Predictable Risks and Evolving Threats

J. Ironside, G. Di Minno, A. Tiede, 2013, Seminars in Thrombosis & Hemostasis.

Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies

F. Ceccherini‐Silberstein, V. Vullo, N. Caporaso, 2017, Liver international : official journal of the International Association for the Study of the Liver.

HCV resistance compartmentalization within tumoral and non‐tumoral liver in transplanted patients with hepatocellular carcinoma

F. Ceccherini‐Silberstein, G. Tisone, T. Manzia, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life.

F. Baldanti, F. Ceccherini‐Silberstein, E. Teti, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Optimal ef fi cacy of interferon-free HCV retreatment after protease inhibitor failure in real life Clinical Microbiology and Infection

F. Ceccherini‐Silberstein, S. Babudieri, I. Lenci, 2017 .

Characterization of drug resistance mutations in naïve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon

M. Andreoni, V. Colizzi, J. Torimiro, 2012, Journal of medical virology.

Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants

Pascal Clayette, M. Turco, D. Salvemini, 2001, Trends in Neurosciences.

Prevalence and outcome of patients with acute myocarditis and positive viral search on nasopharyngeal swab

C. Giannattasio, M. Bramerio, G. Veronese, 2021, European journal of heart failure.

Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real‐life study

F. Ceccherini‐Silberstein, G. Barbarini, R. Sacco, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy.

P Pezzotti, A Cozzi-Lepri, A N Phillips, 2001, The Journal of infectious diseases.

Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.

D. Kuritzkes, J. Schapiro, J. Polli, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.